RS

Ritesh Singh

Active Director Director DIN 08653079
DIN 08653079 First appointment Dec 2019 Primary industry Electrnoics
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2019
Shareholding value •••• Premium profile

About Ritesh Singh

Data last updated:

Ritesh Singh is a Director at Acuvea Pharma Private Limited (since 2019). The company operates in Electrnoics. Acuvea Pharma Private Limited reported revenue of ₹42.4 Lakh (FY 2025).

DIN 08653079
Primary Designation Director
Industry Electrnoics
First Appointment 30 Dec 2019
Oldest Company Age 6 yrs
Largest company Acuvea Pharma Private Limited · ₹42.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acuvea Pharma Private Limited U52609MH2019PTC335181
Director30 Dec 20192019₹42.4 Lakh (FY 2025)Active

Board colleagues of Ritesh Singh

Directorship timeline

Open interactive timeline →
Acuvea Pharma Private Limited
Premium access

Shareholding and investment profile for Ritesh Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ritesh Singh

Ritesh Singh currently holds 1 directorship: Acuvea Pharma Private Limited (Director, since 30 Dec 2019, revenue ₹42.4 Lakh (FY 2025)).

Ritesh Singh was first appointed on 30 Dec 2019 as Director at Acuvea Pharma Private Limited.

The current boards of Ritesh Singh's companies include Nitu Singh (Acuvea Pharma Private Limited), Rakesh Kumar Singh (Acuvea Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available